Cephalon's Paul Harmon joins IPHA board
Published on: 10/01/11
Cephalon’s Paul Harmon has been elected to the prescription medicines division strategy board of Irish pharma association IPHA, a role he will serve in for three years.
Paul joined Cephalon Pharma (Ireland) Limited in 2006 as national sales manager and was appointed as business unit director Ireland and chief representative to IPHA in 2008.
He has over 10 years experience in the pharmaceutical and biopharmaceutical industry in Ireland and internationally, having joined Pfizer Healthcare Ireland in 1999 following a stint in mental health nursing.